コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ind leg prior to CIP was used for peripheral nerve block.
2 rates of peripheral compared with neuraxial nerve blocks.
3 em to bring better evidences than those with nerve blocks.
4 for pain management including utilization of nerve blocks.
5 onitoring options when performing peripheral nerve blocks.
6 usage of ultrasound guidance for peripheral-nerve blocks.
7 uide the placements of continuous peripheral nerve blocks.
8 o different from single injection peripheral nerve blocks.
9 ng and improving the use of lower peripheral nerve blocks.
10 further increased the utility of peripheral nerve blocks.
11 improve the performance of lower peripheral nerve blocks.
12 and measurement of efficacy for sympathetic nerve blocks.
13 evaluation, therapy may include medication, nerve blocks, active physical therapy, behavioural inter
15 s from 198 consecutively performed foraminal nerve blocks and foraminal epidural injections in the th
18 lgesics and ambulatory continuous peripheral nerve blocks are encouraged to achieve adequate postoper
21 esia, regional analgesia, critically ill and nerve blocks, as well as a search of the Cochrane Librar
22 interest is the use of continuous peripheral nerve blocks at home and their potential effect upon hos
24 asing interest in lower extremity peripheral nerve blocks because of their potential advantages and c
25 movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blo
27 ere we show that prolonged sensory-selective nerve block can be produced by specific concentrations o
33 linical studies on neuraxial anaesthesia and nerve blocks did not bring so far a strong conclusion to
34 ree sequential SDL injections resulting in a nerve block duration of 18.1 +/- 3.4 d delayed the onset
36 ferent cVNS enabled by complete afferent KES nerve block enhances the anti-inflammatory benefits of c
39 ity of paired efferent cVNS and afferent KES nerve block for achieving selective efferent cVNS, speci
40 studies into the clinical use of peripheral nerve blocks for anesthesia and postoperative analgesia
41 loss was statistically greater in the vagal nerve block group (P = .002 for treatment difference in
42 At 12 months, 52% of patients in the vagal nerve block group achieved 20% or more excess weight los
43 In the intent-to-treat analysis, the vagal nerve block group had a mean 24.4% excess weight loss (9
44 ated serious adverse event rate in the vagal nerve block group was 3.7% (95% CI, 1.4%-7.9%), signific
45 he adverse events more frequent in the vagal nerve block group were heartburn or dyspepsia and abdomi
47 ss for anesthesia providers, many peripheral-nerve blocks have become quite amenable to being placed
49 tivity in the field of continuous peripheral nerve blocks in the ambulatory setting and places it in
51 rm deprivation of sensory input by ischaemic nerve block (INB) leads to functional reorganization in
53 plasticity model, in which forearm ischemic nerve block (INB) was combined with low-frequency repeti
54 gesia with continuous epidural or peripheral nerve block infusions, judicious opioids, acetaminophen,
55 d from eosinophils to airway parasympathetic nerves blocks inhibitory M(2) muscarinic receptors on th
57 ations associated with continuous peripheral nerve blocks is very low and probably no different from
60 sibilities afforded by the use of peripheral nerve blocks mainly consist of prolonged analgesia, sele
61 uroprosthetic devices, whereas the on-demand nerve-blocking mechanism could offer effective clinical
62 in perfusion of [(14)C] sucrose; bupivacaine nerve block of CIP caused an attenuation of [(14)C] sucr
63 dies in humans, the effect of a differential nerve block on itch produced by intradermal insertion of
64 he differences between plasticity induced by nerve block or damage versus that induced by experience.
65 n-relieving treatments, including peripheral nerve block or spinal clonidine, an alpha2-adrenergic ag
69 of local anesthetic required to accomplish a nerve block, reducing the potential for systemic toxicit
70 2004 using the search terms critically ill, nerve blocks, regional analgesia, and regional anesthesi
73 There is increasing interest in peripheral nerve blocks, single or continuous, mainly for periopera
74 the use of ambulatory continuous peripheral nerve blocks such as the interscalene, infraclavicular a
78 oscopically directed thoracic intraforaminal nerve blocks that showed few complications and anatomica
79 catheters for the performance of continuous nerve blocks, the use of adjuvants to extend the duratio
80 tients with morbid obesity, the use of vagal nerve block therapy compared with a sham control device
82 rn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned pla
83 with kilohertz electrical stimulation (KES) nerve block to preferentially activate efferent pathways
85 the safety and efficacy of novel peripheral nerve blocks, transversus abdominis plane and ultrasound
86 greatly increasing the number of triggerable nerve blocks (up to nine triggerable events upon a singl
89 jectives were to determine whether the vagal nerve block was superior in mean percentage excess weigh
90 similar compounds can provide very prolonged nerve blocks with minimal systemic and local toxicity.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。